12 Dec 2017
N+1 Singer - Abzena - Recent contract wins support H2 weighting
Abzena’s interim results highlight continued investment across its increasingly integrated Services offering. Performance for the full year is expected to be H2 weighted, with a stronger H2 propelled in particular by recent chemistry research services contract wins and a revitalised biology research services offering. The installation of bioreactors in San Diego is on track, with the first (500l), bioreactor due for installation this month and a second (2,000l) to follow in Q1. Meanwhile, the le ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Abzena - Recent contract wins support H2 weighting
Abzena (ABZA:LON) | 0 0 (-0.9%) | Mkt Cap: 54.0m
- Published:
12 Dec 2017 -
Author:
Dr Jens Lindqvist -
Pages:
3
Abzena’s interim results highlight continued investment across its increasingly integrated Services offering. Performance for the full year is expected to be H2 weighted, with a stronger H2 propelled in particular by recent chemistry research services contract wins and a revitalised biology research services offering. The installation of bioreactors in San Diego is on track, with the first (500l), bioreactor due for installation this month and a second (2,000l) to follow in Q1. Meanwhile, the le ....